Biocracked
Approach: Macro science (tissue). Palette: B, warm.

Extreme macro photograph in the style of a microscopy image, showing a cluster of rounded, translucent golden fat cells (adipocytes) in the foreground. Fine strands of pale pink-red muscle fibers run diagonally across the frame behind them. Between the two tissues, tiny glistening droplets drift along a thin capillary, suggesting a signal travelling from fat to muscle. Shot at a slight low angle with shallow depth of field, so the foreground cells are crisp and the muscle fibers melt into soft blur. Lit by warm amber backlight that makes the fat cells glow like honey, with copper-toned shadows and a faint rim of light on the fiber edges. One small electric green fluorescent speck sits inside a single droplet as the only cool accent. The mood is quiet, curious and intimate, with a sense of hidden communication inside the body.
Longevity

The Fat-Derived Messenger That May Shield Muscle When NAD+ Rises

Nova Chen · · 4 min read

If you take NMN or NR to hold on to muscle as you age, you probably picture the NAD+ going straight into your muscle fibers. A new mouse study suggests the story may be stranger. Part of the benefit appeared to start in fat tissue, which responded to higher NAD+ by sending a protective signal through the blood to muscle.

This is animal research. It does not tell us what NMN or NR will do in people. It does offer an unusual look at how NAD+ biology might work across organs.

The surprise: a messenger from fat

The paper, published in Cell Metabolism by Liang, Li and colleagues at the Chinese Academy of Medical Sciences and Peking Union Medical College, starts with a familiar problem. Loss of skeletal muscle mass is a major driver of frailty and disability. Researchers still don't fully understand how whole-body metabolic cues protect muscle.

The team identified Serpina3n, an adipokine (a signaling protein released by fat tissue), as a key mediator of the muscle-protective effects of NAD+ supplementation in their models.

The proposed chain of events, as described in the abstract:

  1. NAD+ rises in adipose tissue.
  2. This activates STAT1-dependent transcription of the Serpina3n gene.
  3. Serpina3n is released into the bloodstream.
  4. Muscle is protected against atrophy.

This is a different picture from the usual one, in which NAD+ precursors act mainly inside the muscle cell. Here, fat functions as a sensing and signaling organ that converts a metabolic cue into a message for muscle.

Protection across three different kinds of muscle loss

The protective effect was reported across models of aging, disuse and cancer cachexia. These differ in important ways:

  • Aging-related loss develops slowly and involves hormonal, inflammatory and metabolic changes.
  • Disuse atrophy follows immobilization or inactivity, such as bed rest or a cast.
  • Cancer cachexia is a severe wasting syndrome driven by tumor-related inflammation and metabolic disruption.

A mechanism that held up in all three suggests it touches something fairly basic about how muscle maintains itself. The abstract doesn't say how large the effects were in each model, so the strength of protection can't be judged from the summary alone. Models are also not the same as the human conditions they imitate.

What Serpina3n does inside muscle

Once Serpina3n reaches muscle, the authors report that it preserves pyruvate carboxylase protein levels. Pyruvate carboxylase is a mitochondrial enzyme that feeds the TCA cycle, the central energy-producing pathway of the cell. That process is called anaplerosis.

In simple terms, the TCA cycle needs a steady supply of intermediates, and anaplerosis keeps them topped up. According to the authors, keeping pyruvate carboxylase intact supports three things:

  • anaplerosis,
  • oxidative metabolism,
  • protein synthesis.

This fits a broader view that muscle wasting is partly a metabolic problem. If the cell's energy and building-block supply falters, protein breakdown can outpace protein building. Serpina3n appears to help hold that machinery together.

The patent and what it signals

The conflict-of-interest statement notes that three authors (J.L., N.L. and J.H.) filed a provisional patent on using Serpina3n as a strategy to treat muscle atrophy. That is common in translational research and doesn't invalidate the findings, but it shows where the authors see the commercial potential: a targeted protein-based approach, not a supplement. Independent replication will matter.

What this means for NMN and NR users

The temptation is to read this as a reason to feel better about a supplement stack. Some caution is needed.

What it does suggest:

  • NAD+ biology may work through inter-organ communication, not only direct effects in muscle.
  • Fat tissue may be an important and overlooked part of how NAD+ boosting influences muscle.

What it does not show:

  • It does not show that taking NMN or NR raises Serpina3n in people. The summary doesn't address specific precursors or human dosing, and none should be inferred.
  • It does not show that any dose, form or schedule protects human muscle.
  • It does not show that Serpina3n works the same way in humans, or that it is safe to raise.

The study is mouse work, and the abstract doesn't report human data. Many promising findings in rodents fail to translate, partly because mouse and human NAD+ metabolism and body composition differ.

Pairing with resistance training

Nothing in this paper tests exercise, so any link here is inference. Still, the practical hierarchy for muscle preservation is clear from other work: resistance training and adequate protein intake are the best-established tools for maintaining muscle with age. A supplement, if it helps at all, would be an add-on to those basics rather than a replacement.

It also fits that disuse was one of the models studied. Staying active is the most direct way to avoid disuse atrophy, whatever happens to NAD+ levels.

Open questions

  • Do NAD+ precursors raise Serpina3n in human fat tissue? The abstract doesn't say, and this is the key translational question.
  • Is there a human equivalent? Serpina3n is a mouse protein; the closest human relative is SERPINA3, and how well the findings carry over isn't established here.
  • Is raising Serpina3n safe long term? Serpins regulate proteases and inflammation, so systemic elevation could have effects beyond muscle.
  • How does body composition matter? If fat tissue is the source, people with very low or very high fat mass, or with dysfunctional adipose tissue, may respond differently.
  • Does it add to exercise? Combination studies would be needed.

The bottom line

This study offers an intriguing new idea: NAD+ may protect muscle partly by prompting fat tissue to release Serpina3n, which helps muscle keep a key metabolic enzyme and sustain protein synthesis. It is a mechanistic mouse finding, not a supplementation guideline. For now, the sensible takeaway is curiosity rather than change: keep training, eat enough protein, and treat NMN and NR as unproven for muscle preservation in humans until clinical data arrive.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette D, bold color field.

A single AA-style cylindrical battery, shown as a real physical object with a matte metal casing, stands upright at the center of a saturated tomato-red seamless paper backdrop. Its top half is bright and glossy, while the lower half is scuffed and dull. A thin, crisp line of electric green liquid light fills the clear gauge window along its side, stopping about three-quarters of the way up. Three smaller, identical dead batteries lie tipped over in the foreground, slightly out of focus, to suggest the rival compounds. The camera sits at a low three-quarter angle with a shallow depth of field. A hard, warm key light from the upper left casts a sharp, long shadow across the red surface. The mood is punchy and skeptical: one cell charged, the others spent.
supplements

NMN vs NR vs NADH: One Lifted Endurance, None Fixed Fatigue

BY NOVA CHEN ·

A new network meta-analysis of 27 studies and 1,599 adults compared NMN, NR, NADH and nicotinamide, and the results are not what supplement marketing promises. NMN showed a dose-dependent boost in endurance, with a standardized mean difference of 1.02 at the high dose. NADH led for cognition, but mostly in cognitively impaired groups and with a result sensitive to influential studies. The surprise is that no precursor significantly improved perceived fatigue or sleep. Here is how the ranking breaks down, what the limits are, and who should or shouldn't bother.

Approach: the human outcome. Palette: natural.

A tight, low-angle shot of an elderly person's hands gripping a smooth wooden cane at the top of a sunlit garden path. The hands are weathered and slightly tremulous, with visible veins and thin, spotted skin. Behind them, the blurred figure of a seated older man in a cardigan is just recognizable, with his face out of frame. Warm late-morning daylight comes from the side and picks out the grain of the wood and the texture of the skin. The background is soft green foliage and a gravel path in shallow depth of field. The tones are plant greens, honeyed wood and natural skin. A single fresh leaf in vivid electric green sits in the lower foreground. The mood is quiet, honest and reflective, and it suggests fragility without drama.
longevity

Frail Seniors Had Lower Blood NAD+. What That Means for NMN/NR

BY HELIX WARD ·

A new GeroScience study of 529 older Japanese adults found that those with frailty had slightly lower NAD+ in their blood, with about 13% lower odds of frailty per 1 µmol/L increase. But the study was cross-sectional, included only 32 frail participants, and the difference in medians was just 24 versus 25 µmol/L. The link also weakened after adjusting for hematocrit, suggesting blood cell composition may explain part of it. Here is what the findings really say, why they don't show that NMN or NR prevent frailty, and what to consider if you're thinking about NAD precursors.

Approach 1, macro science, in palette D, bold color field.

Extreme close-up microscopy-style image of a single mouse oocyte, a translucent spherical egg, shot straight on at its equator. Inside the cytoplasm, hundreds of mitochondria appear as tiny glowing grains. Most are a muted grey-amber, while a scattered subset of small and large organelles glows vivid electric green (#00e676), clustered unevenly to suggest an uneven response. Fine granular cumulus cells cling to the egg's edge, slightly out of focus. The backdrop is a saturated, flat magenta-violet field, with soft rim light wrapping the egg's glassy membrane and shallow depth of field blurring the edges. The mood is quiet, precise and slightly uneasy, a closer look revealing what the averages hid. Photoreal confocal-meets-studio look, with no text and no labels.
longevity

NMN Rejuvenated Hidden Mitochondria in Aged Eggs, But Not Evenly

BY NOVA CHEN ·

Aged mouse eggs looked mitochondrially normal on average, but a new single-organelle study says the averages were hiding something. Specific subpopulations, high-membrane-potential and small mitochondria, carried elevated mtDNA copy number with age. NMN pulled those back toward young levels, yet pushed large mitochondria the opposite way, and in surrounding cumulus cells it overshot young levels in some groups. No fertility or pregnancy outcomes were measured, the work was in mice, and some authors have patent and company ties. Here is what it means, and does not mean, for women weighing NMN for fertility.

Approach 4, conceptual metaphor, in palette D, bold color field.

A single glass beaker-shaped water carafe sits at center frame on a saturated tangerine-orange seamless backdrop, photographed straight-on at slight low angle. The carafe is filled with clear water, and a small, cleanly drilled hole near its base releases a thin, steady stream that falls into a shallow white ceramic dish below, with a few droplets frozen mid-air. This stands for NAD+ draining away through a leak. A tiny electric green (#00e676) rubber stopper is held by a gloved fingertip entering from the right, about to plug the hole. Lighting is crisp, high-key studio light from upper left, giving sharp specular highlights on the glass and soft, warm-neutral shadows on the backdrop. Mood: clever, precise, optimistic but skeptical. No text or labels.
longevity

The NAD+ Thief in Your Brain: Blocking CD38 Raised Brain NAD+

BY NOVA CHEN ·

Everyone talks about boosting NAD+, but a new preclinical study spotlights the enzyme that may be draining it: CD38. A brain-penetrant inhibitor called CVN14 raised brain NAD+ in rats and mice, and it did nothing in mice lacking CD38. In Parkinson's models, it was linked to better dopaminergic neuron survival in culture and improved motor function in rats. But this is an experimental drug from Cerevance, tested in animals and cells, and all authors work for the company. Here is what it does and does not mean for NMN and NR buyers.

This page is available in